• All
  • Blogs
  • Fact Sheets
  • Glossary
  • Infographics
  • Mentions
  • Press Releases

Abcentra Names Kevin B. Bacon, Ph.D. Chief Executive Officer

Experienced Industry Leader Elevates Research and Development Capabilities, Joins Company At An Important Development Juncture


Advancing the Treatment of Coronary Heart Disease by Targeting Arterial Inflammation

Responsible for over 840,400 deaths and nearly 1.8 million cases of heart attack and stroke each year, CVD is the leading cause of death in the U.S.

Abcentra Reducing Need for Surgery in Aortic Valve Disease

By targeting specific mechanisms, Abcentra aims to make a surgical disease into a medically treatable disease for patients at risk.

The New Medical Frontier